Atea Pharmaceuticals, Inc.AVIRNASDAQ
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank71
3Y CAGR+19.1%
5Y CAGR-30.0%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+19.1%/yr
Annual compound
5Y CAGR
-30.0%/yr
Recent acceleration
Percentile
P71
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.06 | +64.2% |
| 2024 | 0.64 | +40.4% |
| 2023 | 0.46 | -26.7% |
| 2022 | 0.63 | -40.1% |
| 2021 | 1.04 | -83.4% |
| 2020 | 6.29 | -95.1% |
| 2019 | 128.26 | +1614.9% |
| 2018 | -8.47 | - |